Close Menu

NEW YORK (GenomeWeb) – Swedish biotech firm Symcel announced today that it has received a €3.5 million ($4.1 million) grant to clinically validate its calScreener cell analysis system for use in antibiotic susceptibility testing.

CalScreener is designed to provide real-time cellular bioenergetic measurements using calorimetry, which relies on heat to measure metabolic and physical changes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.